صفحه نخست

HerbMedX

HerbMedX and ZAX Company Sign New Collaboration Agreement to Develop Novel Treatments for Inflammation Disease.

Our goal is to Develop Novel Natural based Treatments with lower side effects, for inflammatory diseases like; Eczema, Psoriasis, and Cutaneous leishmaniasis

Akbar Farjadfar, Ph.D has joined HerbmedX as a senior advisor

We are thrilled to announce that renowned Medical Biotechnologist specialist Dr. Farjadfar has joined HerbmedX as a senior advisor. With a wealth of experience in the field, Dr. Farjadfar will provide valuable insights and guidance to advance the company's biotechnological offerings. His expertise will play a crucial role in shaping HerbmedX's strategic direction and accelerating the development of innovative medical solutions. We are confident that Dr. Farjadfar's contributions will further solidify HerbmedX's position as a leader in the biotechnology industry. Welcome aboard, Dr. Farjadfar!

Last news

HerbmedX has appointed Esmaeil Behmard, Ph.D, a bioinformatics specialist, as the Head of HerbmedXAI department.

With extensive experience in computational biology, Dr. Behmard is poised to lead the company in leveraging artificial intelligence. His expertise will be crucial in developing innovative algorithms and technologies that will enhance the efficacy and safety of herbal products, ultimately benefiting consumers worldwide. The appointment of Dr. Behmard underscores HerbmedXAI's commitment to harnessing cutting-edge technologies to drive advancements in natural healthcare. Welcome aboard, Dr. Behmard!

Eczema

Eczema is the most common chronic inflammatory skin disease. The most important symptoms of this disease include inflammation, dryness, severe itching and increased skin sensitivity. In some cases, atopic dermatitis causes frequent rashes, persistent scratching, erythematous plaques, and small blister that may be accompanied by extracellular fluid leakage.

Learn more

Psoriasis

Psoriasis is one of the most common autoimmune chronic inflammatory skin diseases that affects 125 million people in the world. The most important clinical manifestation of this disease is in the form of scaly erythematous patches and plaques, which mainly involve the body's exposed surfaces such as elbows and knees.

Learn more

Leishmaniasis

Learn more

Cutaneous leishmaniasis (CL) is the most common form and causes skin lesions, mainly ulcers, on exposed parts of the body. These can leave life-long scars and cause serious disability or stigma. About 95% of CL cases occur in the Americas, the Mediterranean basin, the Middle East and central Asia.

About us

Learn more

At HerbmedX, we have gathered experts from the fields of pharmacology, biotechnology, microbiology, bioinformatics, pharmacognosy, ethnopharmacology, and medicine to develope new anti-inflammatory medicines made from natural health products using innovation and new medical advances.